Enterprise Bank & Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$294K Hold
12,119
0.11% 111
2025
Q1
$307K Hold
12,119
0.12% 104
2024
Q4
$322K Buy
12,119
+576
+5% +$15.6K 0.11% 102
2024
Q3
$334K Buy
11,543
+44
+0.4% +$1.28K 0.11% 97
2024
Q2
$322K Buy
11,499
+106
+0.9% +$2.92K 0.11% 94
2024
Q1
$316K Sell
11,393
-2,298
-17% -$63.8K 0.11% 98
2023
Q4
$394K Sell
13,691
-2,812
-17% -$85K 0.14% 86
2023
Q3
$547K Sell
16,503
-481
-3% -$17K 0.23% 66
2023
Q2
$623K Buy
16,984
+1,999
+13% +$77.8K 0.24% 68
2023
Q1
$611K Sell
14,985
-150
-1% -$6.48K 0.26% 69
2022
Q4
$776K Buy
15,135
+1,550
+11% +$74.3K 0.37% 61
2022
Q3
$594K Buy
13,585
+235
+2% +$11.4K 0.31% 65
2022
Q2
$700K Buy
13,350
+150
+1% +$7.64K 0.32% 66
2022
Q1
$683K Sell
13,200
-7,616
-37% -$395K 0.27% 68
2021
Q4
$1.23M Hold
20,816
0.43% 56
2021
Q3
$895K Hold
20,816
0.35% 62
2021
Q2
$815K Hold
20,816
0.32% 63
2021
Q1
$754K Sell
20,816
-203
-1% -$7.21K 0.32% 59
2020
Q4
$774K Buy
21,019
+11,155
+113% +$409K 0.33% 61
2020
Q3
$343K Sell
9,864
-3,884
-28% -$136K 0.16% 65
2020
Q2
$427K Hold
13,748
0.21% 63
2020
Q1
$426K Sell
13,748
-5,710
-29% -$195K 0.25% 61
2019
Q4
$723K Hold
19,458
0.32% 60
2019
Q3
$663K Sell
19,458
-31,441
-62% -$1.14M 0.32% 61
2019
Q2
$2.09M Sell
50,899
-337
-0.7% -$13.4K 1.08% 31
2019
Q1
$2.06M Buy
+51,236
New +$2.05M 0.85% 33

Other funds holding PFE

Enterprise Bank & Trust's PFE Position: Q2 2025 in Review

Enterprise Bank & Trust held its Pfizer (PFE) position steady in Q2 2025 at 12,119 shares worth $294K. The position accounts for 0.11% of the portfolio, ranked #111.

Enterprise Bank & Trust first reported a position in PFE in Q1 2019 and has held it in 26 quarters since. The position peaked at $2.09M in Q2 2019. 2,810 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Enterprise Bank & Trust held 12,119 shares of Pfizer worth $294K as of Q2 2025.
  • Enterprise Bank & Trust left its Pfizer share count unchanged in Q2 2025.
  • Pfizer made up 0.11% of Enterprise Bank & Trust's portfolio in Q2 2025, its #111 holding.
  • Enterprise Bank & Trust first reported a position in Pfizer in Q1 2019 and has held it in 26 quarters since.
  • Enterprise Bank & Trust's Pfizer position peaked at $2.09M in Q2 2019.
  • 2,810 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Enterprise Bank & Trust's 13F filing for Q2 2025, filed 7 Jul 2025.